FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate Cancer
AstraZeneca
Jaleh Fallah; Jianjin Xu; Chana Weinstock; Michael H Brave; Erik Bloomquist; Mallorie H Fiero; Timothy Schaefer; Anand Pathak; Abdelrahmman Abukhdeir; Vishal Bhatnagar; Haw-Jyh Chiu; Tiffany Ricks; Christy John; Salaheldin Hamed; Christal Lee; William F Pierce; Shyam Kalavar; Reena Philip; Shenghui Tang; Laleh Amiri-Kordestani; Richard Pazdur; Paul G Kluetz; Daniel Suzman